Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||
| Net Income | N/A | 3,920 | N/A |
| Depreciation Amortization | N/A | 1,180 | N/A |
| Other Working Capital | N/A | 60 | N/A |
| Other Operating Activity | 0 | -2,330 | 0 |
| Operating Cash Flow | $N/A | $2,830 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | N/A | -2,070 | N/A |
| Other Investing Activity | 0 | 400 | 0 |
| Investing Cash Flow | $N/A | $-1,670 | $N/A |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 0 | 110 | 0 |
| Financing Cash Flow | $N/A | $110 | $N/A |
| Exchange Rate Effect | N/A | 310 | N/A |
| Beginning Cash Position | N/A | 44,650 | N/A |
| End Cash Position | N/A | 46,250 | N/A |
| Net Cash Flow | $N/A | $1,600 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | N/A | 2,830 | N/A |
| Free Cash Flow | 0 | 2,830 | 0 |